Comparison 3. Individuals with a confirmed diagnosis of SARS‐CoV‐2 infection and asymptomatic to mild disease.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 3.1 All‐cause mortality up to longest follow‐up (45 days) | 2 | 4209 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.00 [0.45, 2.22] |
| 3.2 Admission to hospital or death up to day 45 | 2 | 4209 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.79 [0.57, 1.10] |
| 3.3 Thrombotic events | 2 | 4209 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.37 [0.09, 1.46] |
| 3.4 Serious adverse events | 1 | 3881 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.00 [0.60, 1.64] |